Roche To Set Right Avastin Post-Marketing Surveillance Delay In India
Executive Summary
Roche is working towards implementing PMS studies for Avastin (bevacizumab) and ensuring that a suspension of marketing authorization for the product in first line ovarian cancer is lifted in India.